Delhi has less than a day's stock of Covaxin for 45-plus age group: AAP MLA

AAP MLA Atishi said that Delhi has less than a day's stock of Covaxin left for the 45 plus age group and they will have to temporarily shut down centres administering it

Delhi has less than a day's stock of Covaxin for 45-plus age group: AAP MLA
Press Trust of India New Delhi
1 min read Last Updated : May 17 2021 | 6:41 PM IST

AAP MLA Atishi said on Monday that Delhi has less than a day's stock of Covaxin left for the 45 plus age group and they will have to temporarily shut down centres administering it.

The centres administering Covaxin to the 18-44 age group have been closed.

While issuing the vaccination bulletin, Atishi said that Delhi also started walk-in vaccinations for 45-plus, healthcare workers and frontline workers from Monday.

There are many people who don't have smartphones and can't register online, she said, adding that there were 97 schools where such centres have been opened.

"We will have five days stock of Covishield, but less than a day's stock of Covaxin for 45 plus age group after today's vaccination," she said.

Atishi said they have only four days of Covishield left for the 18-44 age group.

"We urge the Centre to supply us vaccines for the 18-44 age group since the new strain of coronavirus is affecting the young people," she said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineAtishi Marlena

First Published: May 17 2021 | 6:39 PM IST

Next Story